E
Emma Zahra
Researcher at National Drug and Alcohol Research Centre
Publications - 10
Citations - 53
Emma Zahra is an academic researcher from National Drug and Alcohol Research Centre. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 6 publications receiving 17 citations. Previous affiliations of Emma Zahra include University of New South Wales.
Papers
More filters
Journal ArticleDOI
Rates, characteristics and manner of cannabis-related deaths in Australia 2000-2018
TL;DR: Low all-cause crude mortality rates remained relatively stable over the study period and men were over-represented in this group and were three times as likely to die of accidental injury than women who died from cannabis-related deaths.
Journal ArticleDOI
Economic analysis of out-of-pocket costs among people in opioid agonist treatment: A cross-sectional survey in three Australian jurisdictions.
Anh Dam Tran,Rory Chen,Suzanne Nielsen,Emma Zahra,Louisa Degenhardt,Thomas Santo,Michael Farrell,Briony Larance +7 more
TL;DR: In this article, the authors examined OAT clients' total out-of-pocket costs (including dispensing fees, travel costs and OAT-related appointment costs) in different treatment settings (public clinics, community pharmacies, and private clinics).
Quantifying the social costs of pharmaceutical opioid misuse and illicit opioid use to Australia in 2015/16
Steve Whetton,Robert J. Tait,Agata Chrzanowska,Neill Donnelly,Alice McEntee,Aquif Mukhtar,Emma Zahra,Gabrielle Campbell,Louisa Degenhardt,Tania Dey,Suraya Abdul Halim,Wayne Hall,Marshall Makate,Richard Norman,Amy Peacock,Ann Roche,Steve Allsop +16 more
Journal ArticleDOI
Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross‐sectional survey of Australian treatment clients
Emma Zahra,Rory Chen,Suzanne Nielsen,A. D. Tran,Thomas Santo,Louisa Degenhardt,Michael Farrell,Jude Byrne,Robert Ali,Briony Larance +9 more
TL;DR: Negative consequences of treatment costs to clients, particularly dosing fees, are evident and impact treatment access and retention that may negatively impact clients' physical health, mental health and social wellbeing.
Journal ArticleDOI
Trends and characteristics in barbiturate deaths Australia 2000-2019: a national retrospective study.
Gabrielle Campbell,Gabrielle Campbell,Shane Darke,Emma Zahra,Johan Duflou,Fiona Shand,Julia Lappin,Julia Lappin +7 more
TL;DR: There were notable differences between age categories, with the youngest age group recording more severe psychiatric histories and the oldest age group were more likely to have severe physical health problems, such as cancer, chronic non-cancer pain, neurological conditions and significant cardiopulmonary morbidity.